Companies: 10,795·Total market cap: $144.5T
Clearmind Medicine Inc.

Clearmind Medicine Inc.

CMNDNASDAQHealthcare● Active
$3.79
$-0.19(-4.77%)
Market Cap$3862135
P/E Ratio—
52W High$524
52W Low$2.1
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Clearmind Medicine Inc. (CMND) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001892500 · CMND · NASDAQ · as of Jun 8, 2026

Filing snapshot

332
Total Filings
6-K
Latest Form
2026-06-01
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001892500 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-01-20
Fiscal Year End
Jan 20, 2026
Accession No.
0001213900-26-005665
Primary Document
ea0271909-20f_clearmind.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001892500 · Accession 0001213900-26-005665

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-01
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-29
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-26
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-19
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-19
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-18
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-18
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-12
View
EFFECTEFFECT
EFFECT
2026-05-07
View
CORRESPCORRESP
CORRESP
2026-05-06
View
UPLOADUPLOAD
UPLOAD
2026-05-06
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-05
View
F-3F-3
REGISTRATION STATEMENT
2026-04-30
View
Showing 1–15 of 332 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001892500  |  Exchange: NASDAQ · Healthcare

Clearmind Medicine Inc. (NASDAQ: CMND) has submitted 332 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001892500, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Clearmind Medicine Inc.'s most comprehensive regulatory disclosure. The most recent Clearmind Medicine Inc. 10-K was filed on 2026-01-20 for fiscal year ending 2026. Historical CMND 10-K annual reports are available from 2021 through 2026.

Investors researching Clearmind Medicine Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
KZIA SEC Filings →XBIO SEC Filings →SILO SEC Filings →SNGX SEC Filings →TTNP SEC Filings →CNSP SEC Filings →CANF SEC Filings →CLDI SEC Filings →
→ CMND Financials→ CMND Earnings→ CMND Insider Trades

Frequently Asked Questions

CMND SEC Filings · 8 questions

Clearmind Medicine Inc. (CMND) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 332 filings and access original documents at no cost. Clearmind Medicine Inc.'s CIK is 0001892500.

CMND SEC filingsClearmind Medicine Inc. SEC documentsfind CMND 10-K